TABLE 1.
Markers | Study design | Study population | Sex | Age,2 y | Study size, n | Cytokine measurement method | RBP4 measurement method | Analysis | Relation | RBP4 specimen | Authors, year (ref) |
Uri-8-isoPGF2α | CC | 101 Subjects with T2D; 22 controls | 62 M; 39 F | 61.6 ± 4.5 | 123 | EIA kit | EIA | Correlation | None | Serum | Takebayashi et al., 2007 (20) |
Urinary 8-isoprostane | CS | Healthy obese and overweight children | 45 M; 38 F | 8–15 | 83 | ELISA | Immunononenephelometry | ANCOVA | + | Serum | Codoñer-Franch et al., 2013 (49) |
Uri-8-isoPGF2α | CS | Chinese | 910 M; 838 F | 50–70 | 1748 | ELISA | ELISA | Correlation | + | Plasma | Liu et al., 2014 (50) |
13-HOD | CS | Chinese | 910 M; 838 F | 50–70 | 1748 | Colorimetric EIA kit | ELISA | Correlation | + | Plasma | Liu et al., 2014 (50) |
Glutathione | CS | Healthy obese and overweight children | 45 M; 38 F | 8–15 | 83 | ELISA | Immunononenephelometry | Multivariate regression | − | Serum | Codoñer-Franch et al., 2013 (49) |
MDA | CC | Normotensive subjects | 111 M; 47 F | 49 | 66 | TBAR | ELISA validated by Western blot | Linear correlation | + | Plasma | Solini et al., 2012 (51) |
CC, case-control; CS, cross-sectional; EIA, enzyme immunoassay; F, female; M, male; MDA, malondialdehyde; RBP4, retinol binding protein 4; ref, reference; T2D, type 2 diabetes; Uri-8-isoPGF2α, urinary 8-iso-prostaglandin F2α 13-HOD, 13-(S)-hydroxyoctadecadienoic acid; +, positive; −, negative.
Values are ranges, means ± SDs, or the median.